Article

Keys to Market Success
for Stroke Intervention
Technologies

Keys to Market Success for Stroke Intervention Technologies

Over the last few decades, endovascular devices for stroke intervention and imaging technologies have become increasingly effective, allowing physicians to successfully treat a broader range of patients experiencing a stroke event.

Neurovascular Device FDA 510(k) Clearances

Technological advancements present a unique challenge for medtech sales teams. Key Opinion Leaders (KOLs), constantly striving to stay at the forefront of stroke care, often resist committing to long-term contracts with device manufacturers, fearing to miss out on emerging, potentially superior technologies. However, with the growing commoditization of neurovascular devices on the horizon, we anticipate a shift in how these devices are marketed and positioned by major manufacturers.

S2N Health has been working with innovators and market leaders in stroke technologies across diagnosis, treatment, and post-stroke care for many years. From this experience, we know that in innovative device markets such as the one described here, commercial strategies must be incredibly nimble for medtech companies to stay ahead of the curve. Here’s how commercial teams can adapt:

  • Understand Early Adoption: Gaining insights into physician behavior and use patterns enables sales teams to proactively reach out to KOLs who are likely to be early adopters.
  • Identify Market Trends: The ability to identify emerging trends early allows innovators to adjust their approach and capitalize on new market opportunities.
  • Target Precisely & Engage Effectively: Commercial teams need a clear vision of who to target and how. Having multi-dimensional account- and physician-level data at your fingertips is critical to improve engagement and conversion.

CASE STUDY: Product Roadmap For Neuroendovascular Robotic Technology


RepSignal provides the critical insights to drive high-impact strategies.

Backed by a team at S2N Health industry experts and strategy consultants, RepSignal leverages the powerful combination of curated data and AI, enabling medtech commercial teams to develop and execute winning strategies. RepSignal can be seamlessly integrated with your CRM and analytics platforms, allowing you to target high-value opportunities with precision and craft effective marketing campaigns tailored to a specific customer segment. Keeping your finger on the pulse of market dynamics lets you anticipate trends early, launch products strategically, and stay ahead of your competition.